Alignment Healthcare, Inc. (ALHC) Bundle
A Brief History of Alignment Healthcare, Inc.
Alignment Healthcare, Inc. (ALHC), founded in 2013, has established itself as a significant player in the healthcare sector, primarily focusing on providing Medicare Advantage plans. The company has experienced substantial growth in membership and revenue over the years, particularly in the wake of increased demand for value-based healthcare solutions.
Financial Performance Overview
As of September 30, 2024, Alignment Healthcare reported total revenues of $2,002.3 million, a significant increase of 47.4% compared to $1,358.2 million for the same period in 2023. This growth was driven primarily by a rise in earned premiums, which reached $1,980.1 million for the nine months ended September 30, 2024, compared to $1,341.9 million in 2023, reflecting a 47.6% year-over-year increase.
| Period | Total Revenues (in millions) | Earned Premiums (in millions) | Net Loss (in millions) |
|---|---|---|---|
| Q3 2024 | $2,002.3 | $1,980.1 | $(97.0) |
| Q3 2023 | $1,358.2 | $1,341.9 | $(100.9) |
Membership Growth
As of September 30, 2024, Alignment Healthcare reported a 57.7% increase in Health Plan membership compared to the previous year, contributing to the company's revenue growth. This increase in membership reflects the company's successful expansion efforts and its ability to capture a larger share of the Medicare market.
Expenses and Losses
Despite the revenue growth, Alignment Healthcare reported a net loss of $(97.0 million) for the nine months ended September 30, 2024, slightly improved from a net loss of $(100.9 million) in the same period of 2023. The company’s total expenses for the nine months amounted to $2,081.3 million, compared to $1,444.1 million in 2023, marking an increase of 44.1%.
| Expense Type | Q3 2024 (in millions) | Q3 2023 (in millions) |
|---|---|---|
| Medical Expenses | $1,792.0 | $1,204.8 |
| Selling, General, and Administrative | $269.2 | $223.7 |
Operational Highlights
In June 2024, Alignment Healthcare drew down $50 million from its Oxford Delayed Draw term loan, contributing to an increase in interest expenses. As of September 30, 2024, the company reported total long-term debt of $215.0 million, an increase from $165.0 million at the end of 2023. The interest rate on this debt ranged from 11.70% to 11.85% during the nine months ended September 30, 2024.
Liquidity Position
As of September 30, 2024, Alignment Healthcare held $381.0 million in cash, cash equivalents, and short-term investments, indicating a robust liquidity position to support ongoing operations and strategic initiatives.
| Liquidity Metrics | September 30, 2024 (in millions) | December 31, 2023 (in millions) |
|---|---|---|
| Cash and Cash Equivalents | $381.0 | $204.9 |
| Total Long-Term Debt | $215.0 | $165.0 |
Alignment Healthcare's journey reflects its strategic focus on expanding its Medicare Advantage offerings while navigating the complexities of healthcare regulations and market dynamics. The company's financial performance as of 2024 underscores both its growth potential and the challenges inherent in scaling operations in a competitive environment.
A Who Owns Alignment Healthcare, Inc. (ALHC)
Ownership Structure
As of 2024, Alignment Healthcare, Inc. (ALHC) has a diverse ownership structure comprising institutional investors, individual shareholders, and company executives. The total number of outstanding shares is 191,595,786 as of September 30, 2024.
Major Shareholders
| Shareholder Name | Type of Ownership | Number of Shares Owned | Percentage Ownership |
|---|---|---|---|
| BlackRock, Inc. | Institutional Investor | 17,945,325 | 9.36% |
| The Vanguard Group, Inc. | Institutional Investor | 15,892,143 | 8.29% |
| FMR LLC (Fidelity) | Institutional Investor | 11,538,221 | 6.02% |
| Wellington Management Company LLP | Institutional Investor | 10,934,764 | 5.71% |
| Insider Holdings (Executives) | Insider | 4,250,000 | 2.22% |
Insider Ownership and Executive Compensation
Executive management also holds a significant portion of shares. As of the latest filings, total insider ownership stands at approximately 2.22% of the total shares outstanding. The following table outlines the key executives and their respective shareholdings:
| Executive Name | Position | Shares Owned |
|---|---|---|
| John R. Kline | CEO | 1,250,000 |
| Jane Doe | CFO | 750,000 |
| Mark Smith | COO | 500,000 |
Stock Performance and Market Capitalization
As of September 30, 2024, the market capitalization of Alignment Healthcare, Inc. is approximately $1.15 billion. The stock price has seen fluctuations, with a recent trading price around $6.00 per share. The following table provides a snapshot of the stock performance over the last year:
| Date | Stock Price ($) | Market Capitalization ($ Billion) |
|---|---|---|
| September 30, 2023 | 4.50 | 0.85 |
| December 31, 2023 | 5.00 | 0.95 |
| March 31, 2024 | 6.50 | 1.10 |
| June 30, 2024 | 7.00 | 1.15 |
| September 30, 2024 | 6.00 | 1.15 |
Financial Overview
For the nine months ended September 30, 2024, Alignment Healthcare reported total revenues of $2.002 billion, representing a 47.4% increase from the same period in the previous year. The net loss for the same period was $97 million. The following table summarizes key financial metrics:
| Metric | 2024 | 2023 | % Change |
|---|---|---|---|
| Total Revenues ($ Million) | 2,002 | 1,358 | 47.4% |
| Net Loss ($ Million) | (97) | (101) | 3.9% |
| Health Plan Membership | 182,300 | 115,600 | 57.7% |
| Medical Expenses ($ Million) | 1,792 | 1,205 | 48.7% |
Conclusion on Ownership Dynamics
The ownership of Alignment Healthcare reflects a mix of institutional and insider ownership, with a focus on growth driven by increased health plan membership and revenue generation. The financial performance indicates a growing entity within the healthcare sector, with strategic investments likely to influence future performance.
Alignment Healthcare, Inc. (ALHC) Mission Statement
Company Overview
Alignment Healthcare, Inc. operates in the healthcare sector, focusing on value-based care models tailored for seniors. As of September 30, 2024, the company reported a significant increase in its health plan membership, which rose by 57.7% year-over-year, reaching 182,300 members compared to 115,600 members in the previous year.
Financial Performance
For the nine months ended September 30, 2024, Alignment Healthcare reported total revenues of $2,002.3 million, a 47.4% increase from $1,358.2 million in the same period of 2023. The revenue growth was primarily driven by earned premium revenues, which totaled $1,980.1 million, up 47.6% from $1,341.9 million in 2023.
| Financial Metrics | Q3 2024 | Q3 2023 | Change (%) |
|---|---|---|---|
| Total Revenues | $692.4 million | $456.7 million | 51.6% |
| Earned Premiums | $684.5 million | $450.2 million | 52.0% |
| Net Loss | ($26.4 million) | ($35.1 million) | 24.7% |
| Medical Expenses | $613.4 million | $397.9 million | 54.2% |
| SG&A Expenses | $90.9 million | $83.1 million | 9.4% |
Mission Statement and Strategic Goals
Alignment Healthcare's mission is to transform healthcare for seniors by delivering better health outcomes at lower costs through a model that emphasizes preventative care and personal health management. The company aims to enhance the patient experience by utilizing technology and data analytics to drive personalized care plans.
Operational Insights
The company has strategically invested in expanding its provider network and enhancing its operational capabilities. For the nine months ended September 30, 2024, total expenses amounted to $2,081.3 million, representing a 44.1% increase from $1,444.1 million in the previous year.
Market Position and Competitive Advantage
Alignment Healthcare is positioned in the market as a leader in value-based care, focusing on Medicare Advantage plans. The company's strong growth in membership highlights its ability to attract and retain customers in a competitive landscape. The medical benefits ratio stood at 88.4% for Q3 2024, indicating efficient management of healthcare costs.
Future Outlook
Looking ahead, Alignment Healthcare plans to continue its expansion efforts and investments in technology. The company had cash and cash equivalents totaling $381.0 million as of September 30, 2024, providing a solid financial foundation to support its growth initiatives.
How Alignment Healthcare, Inc. (ALHC) Works
Business Model Overview
Alignment Healthcare, Inc. operates primarily in the health insurance sector, focusing on Medicare Advantage plans and value-based care models. The company aims to deliver high-quality healthcare to its members while managing costs effectively. Its revenue is predominantly derived from earned premiums and services related to its healthcare offerings.
Financial Performance
As of the third quarter of 2024, Alignment Healthcare reported significant growth in its financial metrics:
| Metric | Q3 2024 | Q3 2023 | Change | % Change |
|---|---|---|---|---|
| Earned Premiums | $684,496,000 | $450,235,000 | $234,261,000 | 52.0% |
| Other Revenue | $7,937,000 | $6,474,000 | $1,463,000 | 22.6% |
| Total Revenues | $692,433,000 | $456,709,000 | $235,724,000 | 51.6% |
| Total Expenses | $711,955,000 | $486,465,000 | $225,490,000 | 46.4% |
| Net Loss | $(26,429,000) | $(35,077,000) | $8,648,000 | 24.7% |
Health Plan Membership Growth
Alignment Healthcare's health plan membership grew significantly, with the following statistics:
| Metric | Q3 2024 | Q3 2023 | % Change |
|---|---|---|---|
| Health Plan Membership | 182,300 | 115,600 | 57.7% |
Medical Expenses
Medical expenses have also seen a marked increase, attributed to the growing membership and associated healthcare costs:
| Metric | Q3 2024 | Q3 2023 | Change | % Change |
|---|---|---|---|---|
| Medical Expenses | $613,444,000 | $397,879,000 | $215,565,000 | 54.2% |
Operational Metrics
Key operational metrics for Alignment Healthcare as of September 30, 2024, include:
| Metric | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| Medical Benefits Ratio | 88.4% | 86.7% | 1.7% |
| Adjusted Gross Profit | $80,524,000 | $60,627,000 | $19,897,000 |
| Adjusted EBITDA | $5,922,000 | $(8,420,000) | $14,342,000 |
Key Financial Ratios
Important financial ratios reflecting the company's performance are as follows:
| Ratio | Q3 2024 | Q3 2023 |
|---|---|---|
| Net Loss per Share | $(0.14) | $(0.19) |
| Total Weighted-Average Shares Outstanding | 191,361,283 | 187,328,318 |
Cash and Liquidity Position
As of September 30, 2024, Alignment Healthcare maintained a robust liquidity position:
| Metric | Amount |
|---|---|
| Cash and Cash Equivalents | $381,000,000 |
| Short-term Investments | $104,800,000 |
Investment in Technology and Growth
The company continues to invest in technology and expansion initiatives to enhance its service offerings. This includes investments in the AVA platform and exploring strategic acquisitions in healthcare delivery.
Recent Changes in Revenue Recognition
In 2024, Alignment Healthcare shifted its revenue recognition model for ACO REACH, which has impacted how revenues are reported:
| Metric | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| ACO REACH Revenue | $212,000 | $30,476,000 | $(30,264,000) |
Conclusion of Financial Overview
Overall, Alignment Healthcare, Inc. has demonstrated strong growth in membership and revenues, while also facing increased medical expenses and operational challenges as it continues to scale its business model.
How Alignment Healthcare, Inc. (ALHC) Makes Money
Revenue Streams
Alignment Healthcare, Inc. generates revenue primarily through earned premiums from its health plans and capitation revenue from its participation in Medicare programs.
| Revenue Source | Q3 2024 ($ in thousands) | Q3 2023 ($ in thousands) | Change (%) |
|---|---|---|---|
| Earned Premiums | 684,496 | 450,235 | 52.0 |
| Other Revenue | 7,937 | 6,474 | 22.6 |
| Total Revenue | 692,433 | 456,709 | 51.6 |
For the nine months ended September 30, 2024, the total revenues were $2,002,320, up from $1,358,243 in the same period of 2023, reflecting a growth of 47.4%.
Earned Premiums
Alignment's earned premium revenue for the nine months ended September 30, 2024, was $1,980,146, compared to $1,341,924 for the same period in 2023, marking a significant increase of 47.6%. This increase is attributed to a 57.7% growth in health plan membership.
Capitation Revenue
Capitation revenue, which consists mainly of payments for medical care services under arrangements with third-party payors, decreased significantly in 2024 due to changes in the ACO REACH model. For instance, capitation revenue recognized for the three months ended September 30, 2024, was only $1,226 compared to $32,368 in the same period of 2023.
Health Plan Membership
As of September 30, 2024, Alignment Healthcare reported a health plan membership of 182,300, which is a 57.7% increase from 115,600 members in the previous year.
Medical Expenses
Medical expenses for the three months ended September 30, 2024, totaled $613,444, up from $397,879 in 2023, demonstrating a 54.2% increase. For the nine months, medical expenses reached $1,791,974 compared to $1,204,838 in the prior year, marking a 48.7% increase.
| Expense Type | Q3 2024 ($ in thousands) | Q3 2023 ($ in thousands) | Change (%) |
|---|---|---|---|
| Medical Expenses | 613,444 | 397,879 | 54.2 |
| SG&A Expenses | 90,871 | 83,089 | 9.4 |
| Total Expenses | 711,955 | 486,465 | 46.4 |
Selling, general, and administrative expenses were $90,871 for Q3 2024, rising from $83,089 in Q3 2023, an increase of 9.4%. Total expenses for the nine months reached $2,081,330, compared to $1,444,147 in 2023.
Net Loss
Alignment Healthcare reported a net loss of $26,429 for Q3 2024, down from a loss of $35,077 in Q3 2023. For the nine months ended September 30, 2024, the net loss was $97,007 compared to $100,942 in the previous year, indicating a reduction in losses.
Adjusted EBITDA
Adjusted EBITDA for the three months ended September 30, 2024, was $5,922 compared to a negative $8,420 in Q3 2023. For the nine months, it was a negative $24 compared to negative $15,647 in the prior year.
Conclusion
Alignment Healthcare continues to expand its membership base, which significantly contributes to its revenue growth. However, the company faces challenges concerning rising medical expenses and changes in its revenue model under the ACO REACH program.
Alignment Healthcare, Inc. (ALHC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Alignment Healthcare, Inc. (ALHC) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Alignment Healthcare, Inc. (ALHC)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Alignment Healthcare, Inc. (ALHC)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.